Cases 1 - 9 of 9
Astrazeneca AB et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv01457
Plaintiff:
Astrazeneca AB and AstraZeneca Pharmaceuticals LP
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Bristol-Myers Squibb Company et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv00393
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GMBH et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv00335
Plaintiff:
Bayer Intellectual Property GMBH, Bayer Pharma AG, Bayer AG and others
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. v. ScieGen Pharmaceuticals, Inc. et al
as 1:2021cv01616
Plaintiff:
Merck Sharp & Dohme Corp.
Defendant:
ScieGen Pharmaceuticals, Inc. and Bactolac Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Genentech, Inc. et al v. ScieGen Pharmaceuticals Inc.
as 1:2019cv00132
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
ScieGen Pharmaceuticals Inc. and Bactolac Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. ScieGen Pharmaceuticals Inc.
as 1:2019cv00131
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
ScieGen Pharmaceuticals Inc. and Bactolac Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
UCB Inc. et al v ScieGen Pharmaceuticals Inc. et al
as 1:2013cv01217
Plaintiff:
UCB Inc. , UCB Pharma GmbH , Research Corporation Technologies Inc. and others
Defendant:
ScieGen Pharmaceuticals Inc. and Bactolac Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
